Ranked board
Peptides sold to men: who sells them, and what the trials say
The set of companies writing to men is not the set writing to women, and neither is the order. Four of these rows are the same molecule, bremelanotide, sold to men — and the approved product built on its trials, Vyleesi, carries the label sentence “VYLEESI is not indicated for the treatment of HSDD in postmenopausal women or in men.” That is a regulatory fact quoted from the label, not a claim of ours about how anything works, and it is most of why this board's claim column reads as it does.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
What gets on this board
Every published review with at least one product whose own name or verbatim marketing copy addresses men. Read from the seller's page, never from the brand name — one company here with no gendered name at all sells a men's hormone program alongside a menopause program, and the one company that is literally two sex-segmented brands is on neither audience board. Only the products addressed to men are counted.
What decides the order
Companies we have a paid relationship with are listed first, and we say so here rather than marking individual rows. Within that group and within the rest, the order is the same measured one: how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Being a partner changes where a company sits, never what its numbers say.
What the grading found
3/17
Claims that match the trials
Across every one of these companies' products sold to men that we have graded.
5/16
Name their pharmacy
A telehealth brand is almost never the pharmacy that fills the order.
1
Publish a readable certificate
Of every company reviewed on this site, not just those on this board.
The ranking
Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.
Only the products whose own copy addresses men are counted here. A product addressed to both audiences appears on this board and the women's board alike, which is why some companies are on both with different counts.
| Company | Claims vs. trials | Discloses | Visit |
|---|---|---|---|
Eden Checked August 2026 | 1/1100%
| Testing shown | Visit |
CoreAge Rx Checked August 2026 | 0/10%
| Nothing published | Visit |
Fella Health Checked August 2026 | 1/1100%
| Nothing published | Visit |
Prime Doctor RX Checked September 2026 | 1/1100%
| Nothing published | Visit |
1st Optimal Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Visit |
Alinwell Checked September 2026 | 0/10%
| Pharmacy namedTesting shownCertificate public | Visit |
Invigor Medical Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Visit |
PeptidesRx Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Not linked |
Nex Gen Health Rx Checked September 2026 | 0/10%
| Pharmacy named | Visit |
Lighter You Checked August 2026 | 0/10%
| Testing shown | Visit |
Valhalla Vitality Checked August 2026 | 0/20%
| Testing shown | Visit |
VAULT Men's Health Checked August 2026 | 0/10%
| Testing shown | Not linked |
Believe Health Checked September 2026 | 0/10%
| Nothing published | Visit |
Hone Health Checked August 2026 | 0/10%
| Nothing published | Visit |
Longevixx Checked September 2026 | 0/10%
| Nothing published | Visit |
NEUVÉ Health Checked September 2026 | 0/10%
| Nothing published | Visit |
How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.
What this board does not measure
Whether it works
A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.
Clinical care
We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.
Price
Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.
Product quality
Only 1 of the companies reviewed here publish a certificate of analysis a customer can read, and a certificate is not on this board's ranking axis. Nothing here tells you what is in a vial.
Considered, and not on this board
78 companies were inside this board's candidate net and did not meet its rule. Each one has a published review here, and none was left off for an unflattering result.
- AgelessRx
None of AgelessRx's 6 product pages addresses men. Its copy for Rapamycin (sirolimus), Semaglutide, Sermorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- AHBARx
None of AHBARx's 3 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Alan Health
None of Alan Health's 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Andrew Meds
None of Andrew Meds's 2 product pages addresses men. Its copy for GHK-Cu, CJC-1295 and ipamorelin is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Auren Rx
None of Auren Rx's 6 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Glutathione and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Belle Health
None of Belle Health's 3 product pages addresses men. Its copy for Semaglutide, Sermorelin, NAD+ is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Bliv
None of Bliv's 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Bodybuilding Health+
None of Bodybuilding Health+'s 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- BreezeMeds
None of BreezeMeds's 4 product pages addresses men. Its copy for NAD+ (nicotinamide adenine dinucleotide), Sermorelin, Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- CareBareRX
None of CareBareRX's 4 product pages addresses men. Its copy for Semaglutide, Tirzepatide, NAD+ (nicotinamide adenine dinucleotide), Sermorelin is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Clume Health
None of Clume Health's 3 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Collective
None of Collective's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Defy Medical
None of Defy Medical's 3 product pages addresses men. Its copy for Sermorelin, Semaglutide, Bremelanotide (PT-141) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- DirectMeds
None of DirectMeds's 4 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- DudeMeds
None of DudeMeds's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Edessa
None of Edessa's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Embody
None of Embody's 2 product pages addresses men. Its copy for Semaglutide or tirzepatide, named only as "GLP-1", Tirzepatide, named only as "GLP-1 / GIP" is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Enhance.MD
None of Enhance.MD's 6 product pages addresses men. Its copy for NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide, Semaglutide and tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Eviora MD
None of Eviora MD's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Found
None of Found's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Gala GLP-1
None of Gala GLP-1's 3 product pages addresses men. Its copy for Tirzepatide, Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- GOAL.MD
None of GOAL.MD's 4 product pages addresses men. Its copy for Semaglutide, Tirzepatide, Sermorelin, Nicotinamide adenine dinucleotide (NAD+) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Goldspan Health
None of Goldspan Health's 6 product pages addresses men. Its copy for Tirzepatide, Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Bremelanotide (PT-141) and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- He & She MD
None of He & She MD's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- HealthRX
None of HealthRX's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- HumeCare+
None of HumeCare+'s 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Idgie Health
None of Idgie Health's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Joi + Blokes
None of Joi + Blokes's 5 product pages addresses men. Its copy for Tirzepatide, Semaglutide, Sermorelin, Vasoactive intestinal peptide (VIP) and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Lean Meds
None of Lean Meds's 2 product pages addresses men. Its copy for Sermorelin, Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Live Vital
None of Live Vital's 7 product pages addresses men. Its copy for BPC-157, TB-500 (thymosin beta-4 fragment), CJC-1295 and ipamorelin, MOTS-c and 3 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- LumiMeds
None of LumiMeds's 2 product pages addresses men. Its copy for Semaglutide, NAD+ is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Luvo Health
None of Luvo Health's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, Longevity program (compounds not named) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Magnolia Regenerative Medicine
None of Magnolia Regenerative Medicine's 8 product pages addresses men. Its copy for BPC-157, TB-500 (thymosin beta-4 fragment), Epithalon, MOTS-c and 4 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- MangoRx
None of MangoRx's 3 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Marek Health
None of Marek Health's 5 product pages addresses men. Its copy for Not named on any reachable page — sold as "therapeutic peptides", BPC-157, Tesamorelin, Elamipretide (SS-31) and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Maximus
None of Maximus's 5 product pages addresses men. Its copy for Oxytocin, Sermorelin, Tesamorelin, Semaglutide and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- MEDGm
None of MEDGm's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Mondae
None of Mondae's 3 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- MyDrHank
None of MyDrHank's 3 product pages addresses men. Its copy for Tirzepatide, Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- New Wave Health
None of New Wave Health's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- No BS RX
None of No BS RX's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Nova
None of Nova's 3 product pages addresses men. Its copy for Tesamorelin, NAD+ (nicotinamide adenine dinucleotide), Sermorelin is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- NovoCare Pharmacy
None of NovoCare Pharmacy's 4 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Oak Longevity
None of Oak Longevity's 4 product pages addresses men. Its copy for Sermorelin, Tesamorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Oria Meds
None of Oria Meds's 2 product pages addresses men. Its copy for Semaglutide, NAD+ (nicotinamide adenine dinucleotide) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Pallas Health
None of Pallas Health's 4 product pages addresses men. Its copy for NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Peak Wellness
None of Peak Wellness's 1 product pages addresses men. Its copy for Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Polly (formerly Piper)
None of Polly (formerly Piper)'s 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Regenics
None of Regenics's 6 product pages addresses men. Its copy for Tesamorelin, BPC-157, Epithalon (epitalon), MOTS-c and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Rehydra+ Wellness
None of Rehydra+ Wellness's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, Nicotinamide adenine dinucleotide (NAD+) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Renlo Health
None of Renlo Health's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- RX Bella
None of RX Bella's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Rx.com
None of Rx.com's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- RxSpan MD
None of RxSpan MD's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Science & Co
None of Science & Co's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Sesame Care
None of Sesame Care's 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- SexyMD
None of SexyMD's 2 product pages addresses men. Its copy for Tirzepatide, Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Shed
None of Shed's 6 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione, Bremelanotide (PT-141) with oxytocin and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- SkinnyRx
None of SkinnyRx's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- SnagRx
None of SnagRx's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Solaya MD
None of Solaya MD's 3 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Sprout Health
None of Sprout Health's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Strut Health
None of Strut Health's 6 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Superior Remedies
None of Superior Remedies's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Synergy Rx
None of Synergy Rx's 11 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione, Bremelanotide (PT-141) and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- telos rx
None of telos rx's 10 product pages addresses men. Its copy for BPC-157, TB-500 (thymosin beta-4 fragment 17-23) with BPC-157, CJC-1295 and ipamorelin, GHK-Cu and 6 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- The Edit Health
None of The Edit Health's 6 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Sermorelin and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- TOM Weight Loss
None of TOM Weight Loss's 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Transcend
None of Transcend's 6 product pages addresses men. Its copy for Tesamorelin, Tesofensine, Semaglutide, GHK-Cu and 2 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Trava Health
None of Trava Health's 1 product pages addresses men. Its copy for Semaglutide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Trellis Vitality
None of Trellis Vitality's 5 product pages addresses men. Its copy for Semaglutide, Tirzepatide, Tesamorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Trimi
None of Trimi's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Try Ageless
None of Try Ageless's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- VevaRX
None of VevaRX's 4 product pages addresses men. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione, Bremelanotide (PT-141) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Vyvron
None of Vyvron's 5 product pages addresses men. Its copy for Sermorelin, Nicotinamide adenine dinucleotide (NAD+), Methylcobalamin with methionine, inositol and choline (B12-MIC), Semaglutide and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- WellMedr
None of WellMedr's 6 product pages addresses men. Its copy for Tirzepatide with NAD+ and vitamin B12, Semaglutide with NAD+ and vitamin B12, Tirzepatide with NAD+, L-carnitine and vitamin B12, Tirzepatide and 1 more is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- Wellorithm
None of Wellorithm's 2 product pages addresses men. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
- yourEra
None of yourEra's 3 product pages addresses men. Its copy for Semaglutide, Tirzepatide, GLP-1 microdose (molecule not named) is written to no particular audience, so there is no claim made to men here for us to grade — a fact about its marketing, not about who it will treat.
Frequently asked questions
Why do so many rows here score zero?
Because the largest single product category on this board is bremelanotide sold to men, and the trial program behind that molecule was run in premenopausal women. A claim can be graded as unsupported while the molecule itself has excellent evidence — for a different population and a different endpoint. Each review sets out the searches behind its own verdict.
Is this the same board as the women's one with a different heading?
No, and it would be worth nothing if it were. The two boards are built from different products, hold different companies, and come out in different orders — because the rule reads each seller's own copy rather than the brand over the door. Companies appearing on both are the ones whose product pages address both audiences.
Nothing pinned
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.